Astec Lifesciences (INR)1049.5-35.6 (-3.3%)
Exchange ScripsBSE533138NSEASTECISININE563J01010
Indicators | Value | Signal |
---|---|---|
5-DMA | 1076.14 | Bearish |
10-DMA | 1079.85 | Bearish |
20-DMA | 1080.53 | Bearish |
50-DMA | 1074.85 | Bearish |
100-DMA | 1135.4 | Bearish |
200-DMA | 1174.22 | Bearish |
Field | Sep-2024 | Jun-2024 | Mar-2024 | Dec-2023 | Sep-2023 |
---|---|---|---|---|---|
Promoters | 2 | 2 | 2 | 2 | 2 |
Foreign Investors | --- | --- | --- | --- | --- |
Domestic Investors | 2 | 2 | 2 | 2 | 2 |
Public Investors | 19725 | 19953 | 19846 | 19242 | 18720 |
Government | --- | --- | --- | --- | --- |
Below figures are in Rs. Crores
Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Other Income | 56 | 131 | 105 | 80 |
Operating Profit | -3 | 893 | 1645 | 1195 |
Interest | 252 | 207 | 91 | 48 |
Depreciation | 363 | 337 | 344 | 257 |
Profit Before Tax | -617 | 349 | 1211 | 891 |
Consolidated Net Profit | -469 | 256 | 899 | 650 |
Adjusted EPS | -24 | 13 | 46 | 33 |
Below figures are in Rs. Crores
Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Share Capital | 196 | 196 | 196 | 196 |
Total Reserves | 3493 | 3994 | 3766 | 2892 |
Minority Interest | 2 | 2 | 2 | 1 |
Total Non-Current Liabilities | 2083 | 337 | 381 | 460 |
Total Liabilities | 9750 | 9794 | 9254 | 6776 |
Capital Work in Progress | 1485 | 1124 | 137 | 1117 |
Total Assets | 9750 | 9794 | 9254 | 6776 |
Below figures are in Rs. Crores
Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Cash Flow from Operating Activities | 102 | 747 | 236 | -82 |
Cash Flow from Investing Activities | -1352 | -1125 | -1039 | -731 |
Cash Flow from Financing Activitie | 1250 | 378 | 805 | 813 |
Net Cash Inflow / Outflow | --- | -1 | 2 | 1 |
Astec Lifesciences
1049.5-35.6 (-3.3%)
Symbol | Change% |
---|---|
INDOUS | 328.05(20%) |
SAURASHCEM | 125.29(19%) |
GALAPREC | 1353.05(18%) |
INTELLECT | 1051.9(15%) |
TAJGVK | 402.95(14%) |
Announcing Stock of the Month!